Search Results

There are 3295 results for: content related to: The psychopathological characteristics of treatment discontinuation group in 6-month treatment with paliperidone ER

  1. Paliperidone Extended-Release for the Treatment of Schizophrenia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 10, October 2008, Pages: 1283–1298, Jehan Marino and Joshua Caballero

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.10.1283

  2. Oral paliperidone for schizophrenia

    Intervention Review

    The Cochrane Library

    Abraham M Nussbaum and T S Stroup

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006369.pub2

  3. Modeling the Effectiveness of Paliperidone ER and Olanzapine in Schizophrenia: Meta-Analysis of 3 Randomized, Controlled Clinical Trials

    The Journal of Clinical Pharmacology

    Volume 50, Issue 3, March 2010, Pages: 293–310, Ignacio Ortega, Juan Jose Perez-Ruixo, Kim Stuyckens, Vladimir Piotrovsky and An Vermeulen

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009346057

  4. A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

    Bipolar Disorders

    Volume 12, Issue 3, May 2010, Pages: 230–243, Eduard Vieta, Isaac F Nuamah, Pilar Lim, Eric C Yuen, Joseph M Palumbo, David W Hough and Joris Berwaerts

    Version of Record online : 10 MAY 2010, DOI: 10.1111/j.1399-5618.2010.00815.x

  5. Paliperidone palmitate for schizophrenia

    Intervention Review

    The Cochrane Library

    Abraham M Nussbaum and T S Stroup

    Published Online : 13 JUN 2012, DOI: 10.1002/14651858.CD008296.pub2

  6. You have free access to this content
    Paliperidone palmitate – review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication

    International Journal of Clinical Practice

    Volume 64, Issue 2, January 2010, Pages: 216–239, L. Citrome

    Version of Record online : 3 NOV 2009, DOI: 10.1111/j.1742-1241.2009.02240.x

  7. Risperidone and Paliperidone in the Treatment of Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    L. Ivo Caers, Joris Berwaerts, Pages: 153–192, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch9

  8. Single- and Multiple-Dose Pharmacokinetics and Dose Proportionality of the Psychotropic Agent Paliperidone Extended Release

    The Journal of Clinical Pharmacology

    Volume 49, Issue 11, November 2009, Pages: 1318–1330, Dr Sandra Boom, Dr Krishna Talluri, Mr Luc Janssens, Dr Bart Remmerie, Dr Marc De Meulder, Dr Stefaan Rossenu, Dr Nancy van Osselaer, Dr Marielle Eerdekens and Dr Adriaan Cleton

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009339190

  9. You have free access to this content
    Signalling profile differences: paliperidone versus risperidone

    British Journal of Pharmacology

    Volume 170, Issue 3, October 2013, Pages: 532–545, W P Clarke, T A Chavera, M Silva, L C Sullivan and K A Berg

    Version of Record online : 17 SEP 2013, DOI: 10.1111/bph.12295

  10. You have free access to this content
    Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia

    Clinical Pharmacology in Drug Development

    Volume 4, Issue 4, July/August 2015, Pages: 270–278, Stefaan Rossenu, Adriaan Cleton, David Hough, Herta Crauwels, An Vandebosch, Joris Berwaerts, Marielle Eerdekens, Virginie Herben, Marc De Meulder, Bart Remmerie and Igor Francetic

    Version of Record online : 27 AUG 2014, DOI: 10.1002/cpdd.144

  11. Table of Contents

    The Brown University Psychopharmacology Update

    Volume 18, Issue 3, March 2007, Pages: 1–8,

    Version of Record online : 23 FEB 2007, DOI: 10.1002/pu.20039

  12. No pharmacokinetic interaction between paliperidone extended-release tablets and trimethoprim in healthy subjects

    Human Psychopharmacology: Clinical and Experimental

    Volume 24, Issue 7, October 2009, Pages: 532–539, An Thyssen, Adriaan Cleton, Krishna Talluri, Jos Leempoels, Luc Janssens, Sandra Boom and Marielle Eerdekens

    Version of Record online : 19 AUG 2009, DOI: 10.1002/hup.1049

  13. Augmentation of clozapine with paliperidone in treatment-resistant schizophrenia-A case series

    Acta Neuropsychiatrica

    Volume 23, Issue 1, February 2011, Pages: 51–53, Tinggang Chang, Wenyu Hsu, Siseng Huang, Nanying Chiu and Yicheng Liao

    Version of Record online : 5 JAN 2011, DOI: 10.1111/j.1601-5215.2010.00511.x

  14. You have free access to this content
    Paliperidone: quo vadis?

    International Journal of Clinical Practice

    Volume 61, Issue 4, April 2007, Pages: 653–662, L. Citrome

    Version of Record online : 2 MAR 2007, DOI: 10.1111/j.1742-1241.2007.01321.x

  15. Drug-Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended-Release Tablets in Healthy Participants and Patients with Psychiatric Disorders

    The Journal of Clinical Pharmacology

    Volume 56, Issue 6, June 2016, Pages: 683–692, Bart Remmerie, Jay Ariyawansa, Marc De Meulder, Danielle Coppola and Joris Berwaerts

    Version of Record online : 14 DEC 2015, DOI: 10.1002/jcph.648

  16. Paliperidone in the treatment of delirium: results of a prospective open-label pilot trial

    Acta Neuropsychiatrica

    Volume 23, Issue 4, August 2011, Pages: 179–183, Ho-Kyoung Yoon, Yong-Ku Kim, Changsu Han, Young-Hoon Ko, Heon-Jeong Lee, Do-Young Kwon and Leen Kim

    Version of Record online : 23 MAY 2011, DOI: 10.1111/j.1601-5215.2011.00568.x

  17. You have free access to this content
    Studies on the Acute Toxicity, Pharmacokinetics and Pharmacodynamics of Paliperidone Derivatives – Comparison to Paliperidone and Risperidone in Mice and Rats

    Basic & Clinical Pharmacology & Toxicology

    Volume 107, Issue 2, August 2010, Pages: 656–662, Fengying Sun, Zhengxing Su, Cheng Sui, Chao Zhang, Lijia Yuan, Qingfan Meng, Lirong Teng and Youxin Li

    Version of Record online : 25 MAR 2010, DOI: 10.1111/j.1742-7843.2010.00552.x

  18. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia

    Journal of Psychiatric and Mental Health Nursing

    Volume 15, Issue 10, December 2008, Pages: 792–799, A. JONES

    Version of Record online : 4 NOV 2008, DOI: 10.1111/j.1365-2850.2008.01299.x

  19. Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia

    Early Intervention in Psychiatry

    Volume 4, Issue 1, February 2010, Pages: 64–78, Carla M. Canuso, Cynthia A. Bossie, Joan Amatniek, Ibrahim Turkoz, Gahan Pandina and Barbara Cornblatt

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1751-7893.2010.00165.x

  20. Use of high-conductivity sample solution with sweeping-micellar electrokinetic capillary chromatography for trace-level quantification of paliperidone in human plasma

    ELECTROPHORESIS

    Volume 36, Issue 4, February 2015, Pages: 534–542, Hsiang-Yin Liu, Tzung-Jeng Hwang, I-Lin Tsai and Ching-Hua Kuo

    Version of Record online : 22 JAN 2015, DOI: 10.1002/elps.201400230